Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.
作者信息
Kasami M, Page D L
出版信息
J Clin Pathol. 2002 Nov;55(11):879; author reply 879. doi: 10.1136/jcp.55.11.879.
Abstract
摘要
相似文献
1
Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.雄激素受体在乳腺导管原位癌中的表达：与雌激素和孕激素受体的关系。
J Clin Pathol. 2002 Nov;55(11):879; author reply 879. doi: 10.1136/jcp.55.11.879.
2
Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.雄激素受体及两种雄激素诱导蛋白（载脂蛋白D和胃蛋白酶原C）在乳腺导管原位癌中的表达
Histopathology. 2007 Jun;50(7):866-74. doi: 10.1111/j.1365-2559.2007.02687.x.
3
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.三阴性乳腺癌中的大汗腺癌：大汗腺型浸润性导管癌为雌激素/孕激素受体阴性、雄激素受体阳性的新型定义。
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.
4
Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.雄激素受体表达缺失可能在乳腺高级别导管原位癌向浸润性基底亚型转变中起关键作用。
Hum Pathol. 2008 Mar;39(3):386-92. doi: 10.1016/j.humpath.2007.07.007. Epub 2008 Jan 9.
5
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast.雄激素和雌激素受体作为乳腺导管原位癌预后及潜在预测标志物的作用。
Int J Biol Markers. 2015 Nov 11;30(4):e425-8. doi: 10.5301/jbm.5000163.
6
Comparison of two score systems in Bcl-2 and Bax protein expression in invasive ductal carcinoma of breast and relation with oestrogen and progestrone receptors.
Breast J. 2009 May-Jun;15(3):310-2. doi: 10.1111/j.1524-4741.2009.00727.x.
7
Establishment and characterization of a cell line of human breast carcinoma origin.
Eur J Cancer (1965). 1979 May;15(5):659-70. doi: 10.1016/0014-2964(79)90139-7.
8
The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern.芳香化酶抑制剂在原位导管癌（雌激素受体阳性/孕激素受体阴性/Her-2/neu受体阳性模式）治疗中的作用。
Am J Surg. 2007 Aug;194(2):272-3. doi: 10.1016/j.amjsurg.2006.07.022.
9
Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.原发性导管原位癌（DCIS）与相应局部病变之间乳腺癌受体的克隆性改变。
Eur J Cancer. 2014 Feb;50(3):517-24. doi: 10.1016/j.ejca.2013.10.020. Epub 2013 Nov 22.
10
[Methylation of Runx3 promoter in different breast lesions].[不同乳腺病变中Runx3启动子的甲基化]
Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):447-50.
本文引用的文献
1
Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in apocrine variety.
Breast. 2000 Feb;9(1):23-7. doi: 10.1054/brst.1999.0070.
2
Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.乳腺导管原位癌中雄激素受体的表达：与雌激素和孕激素受体的关系。
J Clin Pathol. 2002 Jan;55(1):14-6. doi: 10.1136/jcp.55.1.14.
3
Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.雄激素受体在乳腺大汗腺化生及大汗腺腺病中的免疫组化定位：与雌激素和孕激素受体的关系
J Clin Pathol. 1999 Nov;52(11):838-41. doi: 10.1136/jcp.52.11.838.
4
Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors.乳腺癌中雄激素受体的免疫组织化学显示及其与其他预后因素的关系。
J Pathol. 1993 May;170(1):31-5. doi: 10.1002/path.1711700106.
5
Correlation of estrogen, progesterone, and androgen receptors in breast cancer.乳腺癌中雌激素、孕激素和雄激素受体的相关性
Am J Surg. 1989 Jun;157(6):577-80; discussion 581. doi: 10.1016/0002-9610(89)90704-6.
Zotero 插件